Adriano Piris Selected Research

Acrospiroma

8/2010	Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
4/2009	Atypical and malignant hidradenomas: a histological and immunohistochemical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adriano Piris Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 10/2002
22	Melanoma (Melanoma, Malignant) 01/2022 - 10/2002
3	Nevus (Nevi) 09/2015 - 12/2009
3	Neoplasm Metastasis (Metastasis) 05/2014 - 08/2010
3	Carcinoma (Carcinomatosis) 05/2014 - 04/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2015 - 02/2015
2	Acrospiroma 08/2010 - 04/2009
2	Lymphatic Metastasis 06/2006 - 05/2003
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Neuroendocrine Carcinoma 01/2020
1	Merkel Cell Carcinoma 01/2020
1	Residual Neoplasm 01/2018
1	Disease Progression 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2016
1	Neuroblastoma 09/2015
1	Pigmented Nevus (Melanocytic Nevus) 09/2015
1	Adenocarcinoma of Lung 06/2015
1	Uveal melanoma 02/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2012
1	Carcinogenesis 01/2012
1	Infections 07/2011
1	Nevi and Melanomas 10/2010
1	Leukemia 07/2009

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2022 - 05/2003
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2004
4	VemurafenibIBA 01/2018 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2015 - 11/2003
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Histones (Histone)IBA 01/2022 - 04/2009
2	CohesinsIBA 01/2022 - 01/2016
2	CytokinesIBA 01/2018 - 07/2014
2	Sorafenib (BAY 43-9006)FDA Link 03/2016 - 01/2012
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2016 - 09/2015
2	Immune Checkpoint InhibitorsIBA 07/2014 - 03/2013
2	Keratin-5 (Keratin 5)IBA 05/2014 - 02/2014
2	LigandsIBA 03/2013 - 12/2007
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 04/2009
2	Biological ProductsIBA 08/2010 - 11/2003
2	vitespinIBA 08/2006 - 10/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2006 - 10/2002
2	VaccinesIBA 08/2006 - 10/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2022
1	InterferonsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	ParaffinIBA 01/2021
1	Circular DNAIBA 01/2020
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	Viral DNAIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2018
1	aldesleukin (Proleukin)FDA Link 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	Mutant Proteins (Protein, Mutant)IBA 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2015
1	Ligases (Synthetase)IBA 06/2015
1	UbiquitinIBA 06/2015
1	Microphthalmia-Associated Transcription FactorIBA 06/2015
1	cediranib (AZD2171)IBA 01/2015
1	PLX 4720IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 09/2014
1	DesminIBA 09/2014
1	MyogeninIBA 09/2014
1	Dactinomycin (Actinomycin)FDA LinkGeneric 09/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2014
1	atezolizumabIBA 07/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2014
1	Estrogen ReceptorsIBA 02/2014
1	Androgen Receptors (Androgen Receptor)IBA 02/2014
1	Perilipin-2IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2013
1	Biomarkers (Surrogate Marker)IBA 07/2013
1	MitogensIBA 07/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2013
1	Ribosomal Protein S6IBA 07/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	Protein Kinases (Protein Kinase)IBA 07/2013
1	Mitogen-Activated Protein KinasesIBA 07/2013
1	Dihydrotachysterol (AT 10)IBA 03/2013
1	dabrafenibIBA 03/2013
1	trametinibIBA 03/2013
1	Valine (L-Valine)FDA Link 03/2012
1	Calcibiotic Root Canal SealerIBA 03/2012
1	V 70 (V70)IBA 01/2012
1	posaconazole FDA Link 07/2011
1	CollagenIBA 12/2009
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2006
1	Peptides (Polypeptides)IBA 08/2006
1	EnzymesIBA 08/2006
1	Complementary DNA (cDNA)IBA 10/2004
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2004

Therapy/Procedure

11	Therapeutics 01/2018 - 06/2006
2	Drug Therapy (Chemotherapy) 09/2014 - 07/2009
2	Immunotherapy 03/2013 - 05/2003
1	Mohs Surgery (Mohs' Micrographic Surgery) 01/2021
1	Aftercare (After-Treatment) 07/2013
1	Transjugular Intrahepatic Portasystemic Shunt 10/2010